CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Return
8.35%
This Quarter Return
+7.05%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$1.14B
AUM Growth
+$78M
(+7.4%)
Cap. Flow
+$567K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7
Top Buys
| 1 |
Avantis US Small Cap Value ETF
AVUV
|
$4.17M |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$3.92M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$3.04M |
| 4 |
Neumora Therapeutics
NMRA
|
$2.82M |
| 5 |
Microsoft
MSFT
|
$2.54M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$19.9M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
$6.15M |
| 3 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
$3.04M |
| 4 |
Schwab International Equity ETF
SCHF
|
$2.54M |
| 5 |
Edwards Lifesciences
EW
|
$2.12M |
Sector Composition
| 1 | Technology | 5.18% |
| 2 | Healthcare | 2.32% |
| 3 | Financials | 1.59% |
| 4 | Consumer Discretionary | 1.18% |
| 5 | Communication Services | 1.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
USBC
251
USBC, Inc.
USBC
$323M
| $233K | 0.02% |
9,250
| – | – |
|
252
iShares US Technology ETF
IYW
$23.1B
| $231K | 0.02% |
1,714
| – | – |
|
253
STMicroelectronics
STM
$24B
| $231K | 0.02% |
+5,337
| New | +$231K |
|
254
Equillium
EQ
$114M
| $230K | 0.02% |
99,688
| – | – |
|
255
Cardiff Oncology
CRDF
$144M
| $228K | 0.02% |
42,747
+11,600
| +37% | +$61.9K |
|
256
iShares Core S&P Small-Cap ETF
IJR
$86B
| $228K | 0.02% |
2,064
| – | – |
|
257
Verizon
VZ
$187B
| $227K | 0.02% |
+5,403
| New | +$227K |
|
258
iShares MSCI EAFE Small-Cap ETF
SCZ
$10.7B
| $223K | 0.02% |
3,524
| – | – |
|
259
iShares Russell 1000 Growth ETF
IWF
$117B
| $220K | 0.02% |
+652
| New | +$220K |
|
260
Travelers Companies
TRV
$62B
| $217K | 0.02% |
+944
| New | +$217K |
|
261
SPDR Portfolio Emerging Markets ETF
SPEM
$13.3B
| $217K | 0.02% |
6,000
-1,512
| -20% | -$54.7K |
|
262
Illumina
ILMN
$15.7B
| $216K | 0.02% |
1,617
-181
| -10% | -$24.2K |
|
263
Duke Energy
DUK
$93.8B
| $216K | 0.02% |
+2,233
| New | +$216K |
|
264
Coca-Cola Europacific Partners
CCEP
$40.4B
| $214K | 0.02% |
+3,063
| New | +$214K |
|
265
Brookfield
BN
$99.5B
| $214K | 0.02% |
+5,116
| New | +$214K |
|
266
Blackrock
BLK
$170B
| $214K | 0.02% |
+257
| New | +$214K |
|
267
CVS Health
CVS
$93.6B
| $214K | 0.02% |
+2,681
| New | +$214K |
|
268
Kroger
KR
$44.8B
| $213K | 0.02% |
+3,737
| New | +$213K |
|
269
L3Harris
LHX
$51B
| $212K | 0.02% |
+993
| New | +$212K |
|
270
Micron Technology
MU
$147B
| $209K | 0.02% |
+1,770
| New | +$209K |
|
271
Halozyme
HALO
$8.76B
| $209K | 0.02% |
+5,128
| New | +$209K |
|
272
TJX Companies
TJX
$155B
| $207K | 0.02% |
+2,038
| New | +$207K |
|
273
Boston Scientific
BSX
$159B
| $206K | 0.02% |
+3,011
| New | +$206K |
|
274
Medtronic
MDT
$119B
| $205K | 0.02% |
+2,349
| New | +$205K |
|
275
General Motors
GM
$55.5B
| $204K | 0.02% |
+4,508
| New | +$204K |
|